These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 8495215)
1. p-Bromophenacyl bromide potentiates hydrogen peroxide formation in human platelets challenged by thrombin and inhibits aggregation. Leoncini G; Aprile B; Maresca M Biochem Mol Biol Int; 1993 Feb; 29(2):317-25. PubMed ID: 8495215 [TBL] [Abstract][Full Text] [Related]
2. N-ethylmaleimide inhibits platelet aggregation and potentiates hydrogen peroxide formation induced by thrombin. Leoncini G Biochem Mol Biol Int; 1994 Aug; 34(1):119-26. PubMed ID: 7849614 [TBL] [Abstract][Full Text] [Related]
3. Interference of bromophenacyl bromide with platelet phospholipase A2 activity induced by thrombin and by the ionophore A23187. Vargaftig BB; Fouque F; Chignard M Thromb Res; 1980 Jan 1-15; 17(1-2):91-102. PubMed ID: 6246654 [No Abstract] [Full Text] [Related]
4. Carrageenan-induced activation of human platelets is independent of phospholipase A2 and of formation of thromboxanes. Vargaftig BB; Fouque F; Chignard M; Dumarey C J Pharm Pharmacol; 1980 Nov; 32(11):740-5. PubMed ID: 6110720 [TBL] [Abstract][Full Text] [Related]
5. Effects of methylglyoxal on platelet hydrogen peroxide accumulation, aggregation and release reaction. Leoncini G; Poggi M Cell Biochem Funct; 1996 Jun; 14(2):89-95. PubMed ID: 8640957 [TBL] [Abstract][Full Text] [Related]
6. Preferential activation of phospholipase A2 by low concentrations of phosphatidic acid with long-chain fatty acids in rabbit platelets. Sato T; Hashizume T; Fujii T J Biochem; 1992 Dec; 112(6):756-61. PubMed ID: 1295883 [TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist. Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957 [TBL] [Abstract][Full Text] [Related]
9. YD-3, a novel inhibitor of protease-induced platelet activation. Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of A23187-induced arachidonic acid liberation by vasopressin is sensitive to genistein in rabbit platelets. Akiba S; Sato T; Fujii T Biochem Mol Biol Int; 1993 Sep; 31(1):135-42. PubMed ID: 8260937 [TBL] [Abstract][Full Text] [Related]
13. [Chemiluminescence of thrombocytes in thrombin-induced aggregation]. Samal' AB; Cherenkevich SN; Khmara NF Vopr Med Khim; 1984; 30(6):12-5. PubMed ID: 6442039 [TBL] [Abstract][Full Text] [Related]
14. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein. Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196 [TBL] [Abstract][Full Text] [Related]
15. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Pignatelli P; Pulcinelli FM; Celestini A; Lenti L; Ghiselli A; Gazzaniga PP; Violi F Am J Clin Nutr; 2000 Nov; 72(5):1150-5. PubMed ID: 11063442 [TBL] [Abstract][Full Text] [Related]
16. Platelet aggregation following exposure of phospholipase-treated platelet rich plasma to hydrogen peroxide. Iatridis SG; Iatridis PG; Kyrkou KA; Markidou SG; Iatridi IS Thromb Res; 1979; 15(5-6):733-41. PubMed ID: 494174 [No Abstract] [Full Text] [Related]
17. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553 [TBL] [Abstract][Full Text] [Related]
18. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro. Lohde C; Bahr T; Labes D; Grupe R Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025 [TBL] [Abstract][Full Text] [Related]
19. The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human platelets. Hofmann SL; Prescott SM; Majerus PW Arch Biochem Biophys; 1982 Apr; 215(1):237-44. PubMed ID: 6807207 [No Abstract] [Full Text] [Related]
20. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase. Paul S; Feoktistov I; Hollister AS; Robertson D; Biaggioni I Mol Pharmacol; 1990 Jun; 37(6):870-5. PubMed ID: 2359405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]